Medical note: This article is for education and does not determine whether an individual patient needs a transplant. Heart-transplant decisions require evaluation by an advanced heart-failure/transplant team.
Quick Answer
A heart transplant is considered when a patient has advanced or end-stage heart failure and the heart can no longer provide an acceptable quality or duration of life despite optimized medical and procedural treatment. It is not decided on the basis of ejection fraction alone. Doctors consider symptoms, repeated hospitalizations, exercise capacity, heart and other-organ function, response to treatment, and the patient’s overall suitability for transplantation. Current international guidance emphasizes timely referral to an advanced heart-failure/transplant team rather than waiting until a patient is critically ill.
When Medicines Are No Longer Enough
When we hear the words “heart transplant,” it can sound like the final chapter of a patient’s cardiac journey.
But clinically, it is often better understood as a new treatment pathway for carefully selected patients with advanced heart failure.
Many people with heart failure can be managed for years with medicines, lifestyle changes, devices, procedures, and close follow-up. The objective is always to improve symptoms, protect heart function, reduce hospitalizations, and help the patient live as normally as possible.
A transplant enters the discussion when these approaches are no longer sufficient.
The important question is therefore not simply:
“How low is the ejection fraction?”
It is:
“Is this heart still capable of supporting the patient’s life adequately despite the best available treatment?”
That distinction is extremely important.
What Is Advanced Heart Failure?
Heart failure does not necessarily mean that the heart has stopped working. It means that the heart is unable to pump enough blood to meet the body’s needs, or can do so only at the cost of high pressures within the heart and circulation.
In advanced heart failure, symptoms become severe or difficult to control despite appropriate treatment. Patients may have recurrent hospitalizations, persistent symptoms, poor exercise capacity, or difficulty tolerating standard heart-failure therapies.
The American Heart Association describes advanced heart failure as a stage in which conventional therapies may no longer provide an adequate quality or duration of life, prompting consideration of advanced therapies such as heart transplantation or durable mechanical circulatory support.
Does a Low Ejection Fraction Mean You Need a Heart Transplant?
Not necessarily.
This is one of the most important misconceptions about heart transplantation.
A very low ejection fraction can indicate severe impairment of the heart’s pumping function, but ejection fraction alone does not determine whether someone needs a transplant.
Doctors look at the complete clinical picture.
For example, two patients could have similarly low ejection fractions but very different outcomes:
One may be stable on medication and living an active life.
Another may repeatedly require hospitalization despite treatment and have severe symptoms with minimal activity.
The second patient’s situation may raise much greater concern for advanced heart failure.
The 2024 ISHLT guidelines recommend assessing multiple clinical indicators and using tools such as cardiopulmonary exercise testing, right-heart catheterization, and heart-failure prognostic assessments when evaluating potential transplant candidates.
When Do Doctors Start Considering a Heart Transplant?
A transplant may be considered when a patient has advanced heart failure despite optimized treatment.
Some warning signs include:
1. Severe Symptoms Despite Treatment
A patient may remain significantly breathless, fatigued, or unable to perform everyday activities even after receiving appropriate heart-failure treatment.
2. Repeated Hospitalizations
Frequent admissions because of worsening heart failure can indicate that the disease is becoming increasingly difficult to control.
3. Poor Exercise Capacity
If a patient becomes exhausted or breathless after very limited physical activity, doctors may investigate whether the heart’s reserve has become severely compromised.
Specialized exercise testing can help assess the heart and body’s ability to respond to increased physical demand.
4. Inability to Tolerate Important Medications
Some patients with advanced disease cannot tolerate otherwise appropriate heart-failure medicines because of low blood pressure, kidney dysfunction, or other complications.
5. Progressive Deterioration
When heart function, symptoms, exercise capacity, or other markers continue to worsen despite treatment, the possibility of advanced therapies may need to be considered.
6. Serious Rhythm Problems or Cardiogenic Shock
Certain patients may develop dangerous ventricular arrhythmias or cardiogenic shock, situations that can require urgent advanced-heart-failure assessment and mechanical circulatory support.
Is a Heart Transplant Always the Only Option?
No.
This is another important point.
Before recommending transplantation, specialists determine whether there are other treatments that could meaningfully improve the patient’s condition.
Depending on the underlying disease, these may include:
- Optimized heart-failure medication
- Coronary interventions
- Valve procedures
- Cardiac resynchronization therapy (CRT)
- Implantable cardiac devices
- Surgical procedures where appropriate
- Mechanical circulatory support such as an LVAD
- Treatment of contributing conditions
The 2024 ISHLT guidance specifically emphasizes confirming that appropriate attempts to optimize cardiac function—including medical therapy and indicated interventions—have been exhausted before proceeding toward transplantation.
So the decision is not:
“Heart is weak → transplant.”
It is closer to:
“Heart failure is advanced → have we exhausted appropriate treatments, and would transplantation or another advanced therapy offer a meaningful benefit?”
What Does “Bridge to Transplant” Mean?
Sometimes a patient is identified as a potential transplant candidate but cannot receive a donor heart immediately.
This creates an important period in which the medical team must keep the patient stable while waiting for transplantation.
This is often called bridging to transplant.
Depending on the patient’s condition, bridging may involve intensive medical management, specialized monitoring, temporary support, or durable mechanical circulatory support.
The 2024 ISHLT guidelines specifically address collaborative treatment while patients are waiting for transplantation and the role of durable mechanical support.
This is where meticulous long-term management can become extremely important.
A Real-World Lesson: Sometimes the Journey to Transplant Takes Years
In clinical practice, some of the most meaningful outcomes do not come from one dramatic procedure.
They come from years of carefully coordinated care.
One such journey involved a young patient with severe dilated cardiomyopathy and extremely poor left-ventricular contractility. His ejection fraction was approximately 10%.
Rather than viewing the situation simply as a number, the focus was on keeping him stable while working toward the ultimate treatment goal—a heart transplant.
He was medically managed and closely monitored over several years while being enrolled in a transplant program in Mumbai.
In 2016, he underwent a heart transplant at Fortis Mulund following coordinated efforts between the treating team and the transplant centre.
The transfer of the donor heart was facilitated through a Green Corridor, allowing the organ to reach the transplant centre within the critical timeframe required.
The story did not end with transplantation.
After initially doing extremely well and regaining near-normal exercise capacity, he later developed significant narrowing in a major coronary artery. This was successfully treated with angioplasty in 2021.
The patient subsequently returned to normalcy.
This journey demonstrates something that is sometimes missed when we talk about transplantation:
A transplant is not a single event. It is part of a continuum of care.
It involves decision-making, medical management before transplantation, coordination between centres, transplantation itself, and lifelong follow-up afterwards.
Why Multidisciplinary Care Matters
A heart transplant cannot be managed by one doctor working in isolation.
Patients being considered for advanced heart-failure therapies may require input from:
- Cardiologists
- Advanced heart-failure specialists
- Cardiac surgeons
- Transplant teams
- Interventional cardiologists
- Critical-care specialists
- Nurses and rehabilitation professionals
- Pharmacists
- Other specialists depending on the patient’s condition
Current guidance emphasizes the importance of specialized, multidisciplinary heart-failure teams in evaluating patients for advanced therapies.
This collaborative approach helps answer an important question:
What treatment gives this particular patient the best chance of meaningful survival and quality of life?
What Happens Before a Heart Transplant?
Being referred for transplant evaluation does not automatically mean that a patient will receive a transplant.
The evaluation is comprehensive.
Doctors assess factors such as:
Heart Function
How severely the heart is affected and how it responds to treatment.
Exercise Capacity
Specialized testing can help determine how much functional reserve the patient has.
Other Organ Function
The kidneys, liver, lungs, and other systems are assessed because advanced heart failure can affect multiple organs.
Overall Health
Other diseases and medical conditions may influence whether transplantation is appropriate.
Infection and Immunological Factors
These can be important in determining transplant suitability.
Ability to Follow Long-Term Care
After transplantation, patients require lifelong medical follow-up and immunosuppressive treatment.
The purpose of this detailed evaluation is to determine whether transplantation is likely to provide a meaningful benefit and whether the risks are acceptable.
Why Timing Matters
One of the most important decisions in advanced heart failure is when to refer a patient for transplant evaluation.
Waiting until the patient is critically unstable can make treatment more complicated.
The American Heart Association recommends timely referral of patients with advanced heart failure to specialized centres so that advanced therapies can be considered when appropriate.
This does not mean every patient referred for evaluation needs a transplant immediately.
Early referral can simply provide an opportunity to:
- Understand the available options
- Optimize treatment
- Monitor progression
- Consider mechanical support when appropriate
- Plan ahead rather than react to a crisis
What Happens After a Heart Transplant?
Receiving a donor heart is a remarkable turning point, but it is not the end of medical care.
A transplant recipient requires lifelong follow-up.
Care includes:
Immunosuppressive medication
Monitoring for rejection
Infection prevention and monitoring
Cardiovascular risk management
Regular cardiac assessment
Medication monitoring
Lifestyle and rehabilitation guidance
The ISHLT guidelines for heart-transplant recipients cover peri-operative care, immunosuppression, rejection, long-term complications, and preventive care.
Why Organ Donation Is So Important
Behind every successful heart transplant is a donor and a donor family. A heart transplant cannot happen without a suitable donor organ becoming available. That makes organ donation more than a medical process. It represents an extraordinary decision that can give another person the opportunity to live. The availability of donor organs remains a fundamental limitation in transplantation, making responsible allocation and appropriate candidate selection essential.
The real-world patient journey described above is a reminder of this human dimension of medicine.
One donated heart can give another person a future.
Is Heart Transplant a Cure for Heart Failure?
A heart transplant replaces a severely diseased heart with a donor heart, but it should not be described as a simple “cure.”
Recipients require lifelong medical care and immunosuppression, and transplantation carries its own risks and potential complications.
For appropriately selected patients with advanced heart failure, however, transplantation can offer a major improvement in survival and quality of life. The American Heart Association notes that advanced-heart-failure patients who wish to prolong survival should be evaluated by a specialized heart-failure team for advanced therapies.
Frequently Asked Questions
What is the main reason someone needs a heart transplant?
The most common reason is advanced heart failure in which symptoms and prognosis remain unacceptable despite optimized medical and procedural treatment. Other conditions, including certain cardiomyopathies and complex congenital or restrictive heart diseases, can also lead to transplant consideration.
What ejection fraction requires a heart transplant?
There is no single ejection-fraction number that automatically means a transplant is required. Doctors consider symptoms, functional capacity, hospitalizations, response to treatment, organ function, and overall prognosis alongside ejection fraction.
Can a person with an ejection fraction of 10% survive without a transplant?
Some patients with very low ejection fraction can remain stable with intensive medical and device-based treatment, while others develop advanced heart failure requiring advanced therapies. The individual clinical situation matters much more than the number alone.
Is a heart transplant the last option?
It can be one of the advanced treatment options for appropriately selected patients with advanced heart failure. Depending on the patient, other options such as medical therapy, devices, procedures, or mechanical circulatory support may be considered.
What does bridge to transplant mean?
It means using medical or mechanical support to keep an eligible patient stable while they wait for a suitable donor heart or proceed toward transplantation.
How long can someone live after a heart transplant?
Outcomes vary considerably depending on age, health, transplant centre, complications, and many other factors. Long-term follow-up is essential because transplantation requires lifelong management.
Key Takeaways
- A low ejection fraction alone does not mean that a heart transplant is necessary.
- Transplant is considered primarily when heart failure becomes advanced despite optimized treatment.
- Repeated hospitalizations, severe symptoms, poor exercise capacity, treatment intolerance, and progressive deterioration can signal advanced disease.
- Other treatments—including medications, devices, procedures, and mechanical circulatory support—may be considered before or alongside transplantation.
- Early referral to an advanced heart-failure team is important.
- Heart transplantation is a multidisciplinary process, not a single procedure.
- Organ donation makes transplantation possible and can give patients with otherwise life-limiting heart disease another opportunity for life.
A Message From the Cardiologist
There is an important difference between having a severely weakened heart and being beyond treatment. Modern cardiology gives us multiple ways to support patients with advanced heart disease. The challenge is recognizing when conventional treatment is no longer enough and making the right decision at the right time.
For some patients, the goal may be to continue optimized medical therapy. For others, a device or procedure may provide the necessary support. And for appropriately selected patients with advanced heart failure, transplantation may offer the best path forward. The decision should never be based on a single test or number.
It should be based on the whole patient, the trajectory of the disease, the available treatment options, and the goal of giving that individual the best possible quality and duration of life.
That is why early evaluation, multidisciplinary collaboration, meticulous management, and timely referral matter so much.
